mitoTev‐TALE: a monomeric DNA editing enzyme to reduce mutant mitochondrial DNA levels
Abstract Pathogenic mitochondrial DNA (mtDNA) mutations often co‐exist with wild‐type molecules (mtDNA heteroplasmy). Phenotypes manifest when the percentage of mutant mtDNA is high (70–90%). Previously, our laboratory showed that mitochondria‐targeted transcription activator‐like effector nucleases...
Main Authors: | Claudia V Pereira, Sandra R Bacman, Tania Arguello, Ugne Zekonyte, Sion L Williams, David R Edgell, Carlos T Moraes |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer Nature
2018-09-01
|
Series: | EMBO Molecular Medicine |
Subjects: | |
Online Access: | https://doi.org/10.15252/emmm.201708084 |
Similar Items
-
Molecular Determinants Involved in the Docking and Uptake of Tumor-Derived Extracellular Vesicles: Implications in Cancer
by: Irene Clares-Pedrero, et al.
Published: (2024-03-01) -
The Blazar Sequence and Its Physical Understanding
by: Elisa Prandini, et al.
Published: (2022-02-01) -
Parsec-Scale Structure and Kinematics of Faint TeV HBLs
by: B. Glenn Piner, et al.
Published: (2016-10-01) -
Unbiased Long-Term Monitoring at TeV Energies
by: María Magdalena González, et al.
Published: (2019-04-01) -
Pseudorapidity distribution of charged hadrons in proton–proton collisions at s=13 TeV
by: V. Khachatryan, et al.
Published: (2015-12-01)